Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating ferric citrate for safety/tolerability in children with hyperphosphatemia related to chronic kidney disease has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Ferric citrate (ferric citrate)

Snippet

Sponsor: Keryx Biopharmaceuticals | Conditions: Hyperphosphatemia Related to Chronic Kidney Disease | Phase 3 | Status: SUSPENDED